FDA grants two designations for GenFleet's drug candidate SLS009
GenFleet Therapeutics has received the US Food and Drug Administration (FDA) designations for its drug candidate SLS009 (GFH009).
Page 4 - Yu Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Yu Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Yu Wang Today - Breaking & Trending Today
GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia
/PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, announced that U.S....
Source: prnewswire.com
IBI351 NDA Under NMPA Review in Advanced KRAS G12C–Mutant NSCLC
The Center for Drug Evaluation of China’s National Medical Products Administration has accepted and granted priority review to the new drug application for IBI351 in the treatment of patients with advanced, KRAS G12C–mutant NSCLC who have received at least 1 prior systemic therapy.
Source: onclive.com
A taste for change? Ethyl vanillin seen in UF/IFAS-bred strawberries
University of Florida scientists have found ethyl vanillin -- an aroma compound in many artificial vanilla-flavored food products -- in a UF/IFAS-bred strawberry.This is a key finding for the food and beverage industry and for the UF/IFAS strawberry breeding program.
Source: wgcu.org
Model clarifies a type of fatal seizures in epilepsy
Sudden unexpected death in epilepsy, or SUDEP, ranks second only to stroke in potential life-years lost due to neurological diseases.
Source: futurity.org